GPX4 and invasive breast carcinoma: The TIMER 2.0 database displayed that the expression of GPX4 was substantially upregulated in Bladder Urothelial Carcinoma, Breast invasive carcinoma, COAD, Esophageal Carcinoma, etc. (Fig. 1A).